Luke Bryan is partnering with Bayer and Kroger to improve access to nutritious food through the "Take Care, Now" campaign, which aims to raise awareness, educate communities, and facilitate access to nutritious food and vitamins in underserved rural areas.

Pairwise, a gene editing technology company, has raised $40 million in Series C funding to accelerate the development of its innovative Fulcrum™ Platform, which aims to improve plant breeding, consumer nutrition, grower economics, and crop climate adaptation.

Bayer's prostate cancer drug darolutamide showed significant reduction in radiological progression or death risk compared to placebo in a Phase 3 trial. The company plans to submit the data to support expanded use approval for darolutamide in metastatic hormone-sensitive prostate cancer.

Darolutamide plus androgen deprivation therapy (ADT) significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer, according to results from the ARANOTE trial.

The digital farming market is expected to grow significantly, driven by technological advancements and government support for precision agriculture. Key players in the market include Bayer, Syngenta, Deere & Company, and CNH Industrial.

The RNAi pesticides market is expected to grow significantly, reaching $5.16 billion by 2034, driven by the increased adoption of integrated pest management and the need for sustainable pest control solutions.

The global rodenticides market is projected to grow from $5.6 billion in 2023 to $7.9 billion by 2030, driven by factors like urban expansion, increased agricultural activity, and climate change. The market is seeing advancements in safer and more environmentally friendly products, with a shift towards natural and eco-friendly rodenticides.

The global regenerative medicine market is experiencing robust expansion, driven by advancements in medical technologies and an increasing focus on innovative treatments. The market is expected to grow at a CAGR of 26.37% from 2024 to 2031, reaching $375.77 billion. North America currently dominates the market, but the Asia-Pacific region is expected to witness the fastest growth.

Le marché mondial des antiacides devrait passer de 6,8 milliards de dollars en 2023 à 7,9 milliards de dollars en 2030, sous l'effet de l'augmentation des troubles gastro-intestinaux, des changements de mode de vie et de la sensibilisation des consommateurs aux remèdes en vente libre. Parmi les facteurs clés, citons l'augmentation de la population âgée, les innovations dans la formulation des produits et le soutien réglementaire aux produits antiacides en vente libre.